TY - JOUR
T1 - Impact of weight on immune cell counts among HIV-infected persons
AU - Crum-Cianflone, Nancy F.
AU - Roediger, Mollie
AU - Eberly, Lynn E.
AU - Ganesan, Anuradha
AU - Weintrob, Amy
AU - Johnson, Erica
AU - Agan, Brian K.
AU - Banks, Susan
AU - Bavaro, Mary
AU - Chun, Helen
AU - Decker, Cathy
AU - Eggleston, Conner
AU - Fraser, Susan
AU - Hairston, Heather
AU - Hartzell, Josh
AU - Johnson, Arthur
AU - Landrum, Michael
AU - Lifson, Alan
AU - Linfesty, Michelle
AU - Macalino, Grace
AU - Maguire, Jason
AU - Merritt, Scott
AU - O'Connell, Robert
AU - Okulicz, Jason
AU - Peel, Sheila
AU - Powers, John
AU - Whitman, Timothy
AU - Wortmann, Glenn
AU - Zapor, Michael
PY - 2011/6
Y1 - 2011/6
N2 - Prior studies have shown that weight may impact immune cell counts. However, few data exist about the relationship of weight and immune cell counts among HIV-infected patients. We examined documented HIV seroconverters (mean window, 15.7 months) in a prospective U.S. Military HIV Natural History Study (1 January 1986 to 20 January 2010). We estimated the association of the time-updated body mass index (BMI) category with changes in immune cell counts from HIV diagnosis across time (mean follow-up of 5.1 years) using multiply adjusted longitudinal linear mixed-effects models. Of 1,097 HIV seroconverters, 448 (41%) were overweight and 93 (8%) were obese at HIV diagnosis. Immune cell counts at HIV diagnosis did not significantly differ by BMI category. In the longitudinal models for those diagnosed before the advent of the highly active antiretroviral therapy (HAART) era, mean postdiagnosis decreases in the white cell count, total lymphocyte count, CD4 count, CD4 percentage, and CD4/CD8 ratio were less as the BMI category increased (all with P values of <0.05). Among HIV seroconverters diagnosed in the HAART era, obese compared to normal-weight patients had significantly smaller increases in CD4 counts, CD4 percentages, and the CD4/CD8 ratio (all with P values of <0.05). Similar findings were also noted among underweight versus normal-weight patients. In conclusion, although BMI was not associated with immune cell levels at the time of HIV diagnosis, weight appears to affect immune cells counts over the course of infection. In the HAART era, being either underweight or obese was associated with smaller increases in several important immune cell levels, including the CD4/CD8 ratio.
AB - Prior studies have shown that weight may impact immune cell counts. However, few data exist about the relationship of weight and immune cell counts among HIV-infected patients. We examined documented HIV seroconverters (mean window, 15.7 months) in a prospective U.S. Military HIV Natural History Study (1 January 1986 to 20 January 2010). We estimated the association of the time-updated body mass index (BMI) category with changes in immune cell counts from HIV diagnosis across time (mean follow-up of 5.1 years) using multiply adjusted longitudinal linear mixed-effects models. Of 1,097 HIV seroconverters, 448 (41%) were overweight and 93 (8%) were obese at HIV diagnosis. Immune cell counts at HIV diagnosis did not significantly differ by BMI category. In the longitudinal models for those diagnosed before the advent of the highly active antiretroviral therapy (HAART) era, mean postdiagnosis decreases in the white cell count, total lymphocyte count, CD4 count, CD4 percentage, and CD4/CD8 ratio were less as the BMI category increased (all with P values of <0.05). Among HIV seroconverters diagnosed in the HAART era, obese compared to normal-weight patients had significantly smaller increases in CD4 counts, CD4 percentages, and the CD4/CD8 ratio (all with P values of <0.05). Similar findings were also noted among underweight versus normal-weight patients. In conclusion, although BMI was not associated with immune cell levels at the time of HIV diagnosis, weight appears to affect immune cells counts over the course of infection. In the HAART era, being either underweight or obese was associated with smaller increases in several important immune cell levels, including the CD4/CD8 ratio.
UR - http://www.scopus.com/inward/record.url?scp=79957974065&partnerID=8YFLogxK
U2 - 10.1128/CVI.00020-11
DO - 10.1128/CVI.00020-11
M3 - Article
C2 - 21525303
AN - SCOPUS:79957974065
SN - 1556-6811
VL - 18
SP - 940
EP - 946
JO - Clinical and Vaccine Immunology
JF - Clinical and Vaccine Immunology
IS - 6
ER -